COVID-19

@forbes.com 3 years ago

Should You Buy Baxter Stock Around $80?

@forbes.com 4 years ago

Here’s Why Perrigo Stock May See Higher Levels In The Near Term

@forbes.com 4 years ago

Should You Buy CVS Health Stock At $70?

@forbes.com 3 years ago

Vertex Pharmaceuticals Stock Is Likely To Rebound From $180 Levels Currently

@forbes.com 4 years ago

Should You Buy uniQure Stock At $30?

@forbes.com 4 years ago

Tyson Foods Stock Can Jump 40%

@forbes.com 3 years ago

Is A Recovery Imminent In Haemonetics Stock After Falling 40% This Year?

@forbes.com 4 years ago

ACADIA Pharmaceuticals Stock Now Looks Oversold At $27 Levels

@forbes.com 3 years ago

Kirby Stock Performance In The Pandemic vs 2008

@forbes.com 4 years ago

Here’s Why Biogen Stock Can Offer Over 35% Gains